Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Kansas City, MO
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Cherry Hill, NJ
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Buffalo, NY
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Mineola, NY
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Syracuse, NY
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Syracuse, NY
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Chapel Hill, NC
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Raleigh, NC
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Akron, OH
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Cleveland, OH
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Columbus, OH
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Portland, OR
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Pittsburgh, PA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Morristown, TN
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Morristown, TN
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Nashville, TN
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Dallas, TX
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Fort Worth, TX
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Houston, TX
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Salt Lake City, UT
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Charlottesville, VA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Norfolk, VA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Richmond, VA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
mi
from
Capital Federal,
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
mi
from
Capital Federal,
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Sherman Oaks, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Temecula, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Temecula, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Denver, CO
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Cromwell, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Cromwell, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Hamden, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Hamden, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Middletown, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Middletown, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Miami, FL
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Marietta, GA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Oak Brook, IL
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Oak Brook, IL
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Cedar Rapids, IA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Rockville, MD
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Farmington Hills, MI
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Ridgeland, MS
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Ridgeland, MS
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Moorestown, NJ
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Moorestown, NJ
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Albuquerque, NM
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Beachwood, OH
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Beachwood, OH
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Portland, OR
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Lincoln, RI
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Lincoln, RI
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Austin, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Dallas, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Houston, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Lake Jackson, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
San Antonio, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
Consultants in Epilepsy and Neurology, PLLC
mi
from
Boise, ID
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
Consultants in Epilepsy and Neurology, PLLC
mi
from
Boise, ID
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
New York University Epilepsy Center
mi
from
New York, NY
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
New York University Epilepsy Center
mi
from
New York, NY
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
University of Pennsylvania - Penn Epilepsy Center
mi
from
Philadelphia, PA
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
University of Pennsylvania - Penn Epilepsy Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials